Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin G4 (IgG4) is one of the four subclasses of human IgG antibodies. It exhibits unique structural and functional properties, including Fab-arm exchange, resulting in functionally monovalent antibodies. IgG4 acts primarily as a blocking antibody, inhibiting inflammatory responses and playing a role in allergy tolerance. Elevated levels are associated with autoimmune diseases and IgG4-related disease, making it a clinically relevant biomarker.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin G4 Antibody (IgG4).